Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1974 Aug;54(2):416–420. doi: 10.1172/JCI107777

Secretion of Parathyroid Hormone in Patients with Medullary Thyroid Carcinoma

Leonard J Deftos 1,2, Jacqueline G Parthemore 1,2
PMCID: PMC301569  PMID: 4847251

Abstract

The secretion of parathyroid hormone (PTH) and calcitonin (CT) was studied in 30 patients with medullary thyroid carcinoma. Most patients with elevated levels of CT were normocalcemic and also had normal basal levels of PTH. Five of six patients with associated hyperparathyroidism were hypercalcemic and had elevated basal PTH levels. Hormone secretion was also studied during infusions with standard and low doses of calcium. PTH unexpectedly increased during 12 of 18 calcium infusions. Such a paradoxical increase in PTH was seen in those patients with the greatest increase in CT and the least increase in calcium during the calcium infusion. Accordingly, increases in PTH concentration during the calcium infusions could be correlated directly with increases in CT and correlated inversely with increases in calcium. These observations suggest that, in some patients with medullary thyroid carcinoma, a further increase in the abnormally elevated CT levels may stimulate PTH secretion. Therefore, at least in acute studies, there may be a functional, as well as a genetic, relationship between the secretion of these two hormones in patients with this thyroid tumor.

Full text

PDF
416

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Deftos L. J., Bury A. E., Habener J. F., Singer F. R., Potts J. T., Jr Immunoassay for human calcitonin. II. Clinical studies. Metabolism. 1971 Dec;20(12):1129–1137. doi: 10.1016/0026-0495(71)90038-2. [DOI] [PubMed] [Google Scholar]
  2. Deftos L. J., Goodman A. D., Engelman K., Potts J. T., Jr Suppression and stimulation of calcitonin secretion in medullary thyroid carcinoma. Metabolism. 1971 Apr;20(4):428–431. doi: 10.1016/0026-0495(71)90105-3. [DOI] [PubMed] [Google Scholar]
  3. Deftos L. J. Immunoassay for human calcitonin. I. Method. Metabolism. 1971 Dec;20(12):1122–1128. doi: 10.1016/0026-0495(71)90037-0. [DOI] [PubMed] [Google Scholar]
  4. Deftos L. J., Powell D., Parthemore J. G., Potts J. T., Jr Secretion of calcitonin in hypocalcemic states in man. J Clin Invest. 1973 Dec;52(12):3109–3114. doi: 10.1172/JCI107510. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Deftos L. J. Radioimmunoassay for calcitonin in medullary thyroid carcinoma. JAMA. 1974 Jan 28;227(4):403–406. [PubMed] [Google Scholar]
  6. Dubé W. J., Bell G. O., Aliapoulios M. A. Thyrocalcitonin activity in metastatic medullary thyroid carcinoma. Further evidence for its parafollicular cell origin. Arch Intern Med. 1969 Apr;123(4):423–427. doi: 10.1001/archinte.1969.00300140069015. [DOI] [PubMed] [Google Scholar]
  7. Hennessy J. F., Gray T. K., Cooper C. W., Ontjes D. A. Stimulation of thyrocalcitonin secretion by pentagastrin and calcium in 2 patients with medullary carcinoma of the thyroid. J Clin Endocrinol Metab. 1973 Jan;36(1):200–203. doi: 10.1210/jcem-36-1-200. [DOI] [PubMed] [Google Scholar]
  8. Melvin K. E., Tashjian A. H., Jr, Miller H. H. Studies in familial (medullary) thyroid carcinoma. Recent Prog Horm Res. 1972;28:399–470. [PubMed] [Google Scholar]
  9. Meyer J. S., Abdel-Bari W. Granules and thyrocalcitonin-like activity in medullary carcinoma of the thyroid gland. N Engl J Med. 1968 Mar 7;278(10):523–529. doi: 10.1056/NEJM196803072781002. [DOI] [PubMed] [Google Scholar]
  10. Oldham S. B., Fischer J. A., Capen C. C., Sizemore G. W., Arnaud C. D. Dynamics of parathyroid hormone secretion in vitro. Am J Med. 1971 May;50(5):650–657. doi: 10.1016/0002-9343(71)90120-3. [DOI] [PubMed] [Google Scholar]
  11. Potts J. T., Jr, Murray T. M., Peacock M., Niall H. D., Tregear G. W., Keutmann H. T., Powell D., Deftos L. J. Parathyroid hormone: sequence, synthesis, immunoassay studies. Am J Med. 1971 May;50(5):639–649. doi: 10.1016/0002-9343(71)90119-7. [DOI] [PubMed] [Google Scholar]
  12. Rodbard D., Rayford P. L., Cooper J. A., Ross G. T. Statistical quality control of radioimmunoassays. J Clin Endocrinol Metab. 1968 Oct;28(10):1412–1418. doi: 10.1210/jcem-28-10-1412. [DOI] [PubMed] [Google Scholar]
  13. Segre G. V., Habener J. F., Powell D., Tregear G. W., Potts J. T. Parathyroid Hormone in Human Plasma: IMMUNOCHEMICAL CHARACTERIZATION AND BIOLOGICAL IMPLICATIONS. J Clin Invest. 1972 Dec;51(12):3163–3172. doi: 10.1172/JCI107143. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Tashijan A. H., Jr, Howland B. G., Melvin K. E., Hill C. S., Jr Immunoassay of human calcitonin. N Engl J Med. 1970 Oct 22;283(17):890–895. doi: 10.1056/NEJM197010222831702. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES